|
Re: MM-302: HERMIONE study
Im delighted to be mistaken.Years of pharmacy practice have made me too cynical. I hope this MM-302 is a breakthrough
As far as Tofacitinib is concerned it is a Stat 3 inhibitor that is being investigated for various cancers. Ill have to do some research on both. When I had my own pharmacy way back when a pharmacist would call me and say "Guess what Paul they are coming out with a Zofran SR or whatever. Nothing more was said. It was understood that Zofran or whatever was going generic. In those days the generics were priced much lower than the brands. Now shamefully the price charged for the generics are skyrocketing.
Glad to be mistaken
Paul
|